HOME
Latest Bulletin:  Ten years of data show SEF Chemo® succeeds with every type of cancer treated!   Despite conventional chemo, most stage III breast cancer patients succumb to the disease.   An 8-Week SEF Chemo® is now available.   Click here to read more.

Welcome to Berkeley Institute International

We welcome you to Berkeley Institute International.  The purpose of this website is to inform cancer patients and their families about our new cancer therapy SEF® Chemo, pronounced “safe” chemo, a side effect-free chemotherapy.

After decades of research, our team of scientists developed a new therapy that reduces the side effects commonly associated with chemotherapy with faster remission rates. Now the cure doesn't have to be worse than the disease.

In an effort to keep things simple, we've set up this user-friendly website to explain a little more about what we do, who qualifies for our therapy, and how to become enrolled. If you have any questions, please feel free to contact us for more information.

Thank you for visiting.


About Dr. Kenneth Matsumura, Medical Director,
ALIN Foundation,
Berkeley, CA USA

Dr. Matsumura is a world-renowned scientist.  He developed the HeartAlarm® Wristwatch that gives advanced warning against heart attacks, invented the bio-artificial liver, and invented the artificial pancreas which in collaboration with Johnson & Johnson, NASA invited onto the Space Shuttle.  His bio-artificial liver has been acclaimed for being one of the Top 10 Most Important Inventions of the 21st Century in Medicine and Science, ranking his bio-artificial liver with YouTube® and iPaD®.  His bio-artificial liver was honored by TIME magazine as an Invention of the Year in 2001.

“Top 10 Most Important Inventions of the 21st Century in Medicine”

“Science Breakthroughs of the 2000s”

A graduate of the University of California Medical School in
San Francisco (1970), he is a member of the American Medical Association and numerous scientific societies.  Details of all his breakthrough medical inventions can be found at www.alinfoundation.com.

With a team of dedicated colleagues, Dr. Matsumura started development of SEF Chemo® (Side Effect-Free Chemotherapy) in Berkeley, CA over 25 years.  Dr. Matsumura and his team discovered this innovative therapy that reduces serious side effects of cancer chemotherapy, while also protecting the immune system from destruction during treatment.  Using the body's own immune system, this new therapy that turns ordinary cancer drugs into powerful, more effective agents that have shown strong, positive responses from patients of many types of cancer.

An idealist at heart, Dr. Matsumura also tends to the poor in the San Francisco Bay Area.  In 2006, he played a key role making California's minimum wage the highest in the world.  Today, he dedicates himself to a world without poverty, volunteering his time at local low-income clinics.  He is creating projects that will make Native American a major player in providing cutting edge medical therapies.  He's also highly involved with social justice programs and other charitable work.

Powerful Therapy Comes of Age

In April 2010, Dr. Matsumura and his colleagues at the ALIN Foundation announced an historic achievement: all cancer patients treated with the SEF Chemo® in 2006 not only went into remission, but remained cancer-free without the toxic side effects normally associated with chemotherapy.

Click to learn more...

Patient Testimonials

from John, Alba, & Esther

John's Testimonial...

John was a patient with early-stage IV bladder cancer that came to the Berkeley Institute in October 2015.  Before coming to us, he was told by his doctors that, even with the best conventional therapy had to offer, he would be not last 1-2 years.  His oncologist started conventional chemotherapy treatments, in which he was "herded into a room with eight others like cattle" and the infusion lasted 8-hours.  ...

Click to learn more...


How SEF Chemo was Developed:  My Personal Story

Dr. Ken Matsumura

Today, large pharmaceutical companies have created a regulatory and marketing environment in which only billion dollar companies can hope to bring out a breakthrough medicine.  The story of how SEF Chemo® was developed outside this environment by a small but innovative Berkeley foundation is a tale of courage, high-risk taking, and of overcoming impossible odds.

Impressed by my concepts and credentials, the United States FDA rushed through the approval of the first clinical trial for Side Effect-Free Chemotherapy® in just four days instead of taking the usual year.  The hard part was over, I thought.  It would be smooth sailing from then on.  That was 1992.

Click to learn more...

Home Therapy Explained Breast Cancer Enrollment Criteria Previous Results How to Enroll Contact Us 

Copyright © 2010-2017
Berkeley Institute International
All Rights Reserved.

Bay Area web design by
Verecom.com   ·   WWWizard.com